title: Dissemination of a class I integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria.
authors: Meriem
authors: M
authors: Touati
authors: Seydina M
authors: SM
authors: Diene
authors: Mazouz
authors: M
authors: Dekhil
authors: Abdelghani
authors: A
authors: Djahoudi
authors: Abdelkarim
authors: A
authors: Racherache
authors: Jean-Marc
authors: JM
authors: Rolain
mesh_terms: D000293:Adolescent; D000328:Adult; D000462:Algeria; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001483:Base Sequence; D002648:Child; D002675:Child, Preschool; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D032023:Integrons / Q000235:genetics*; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology / Q000235:genetics* / Q000302:isolation & purification; D001618:beta-Lactamases / Q000235:genetics* / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; C425108:beta-lactamase bla(vim-2); D001618:beta-Lactamases